Empathic Communication Skills Training to Reduce Lung Cancer Stigma and Improve Patient Care
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-10-07
1232
Participants Needed
12
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating empathic communication skills ECS training for oncology care providers OCPs to help reduce perceived stigma in patients diagnosed with lung cancer. The study aims to improve medical and psychosocial care by fostering de-stigmatizing interactions between patients and their care providers. This research builds on prior findings and focuses on enhancing communication in lung cancer clinical encounters to support patient well-being and quality of care.
The trial compares ECS training against a waitlist control group WLC for OCPs. The ECS training is a 2.25-hour behavioral module designed to improve providers recognition and response to patients empathic needs, alleviate stigma, and support patients who have smoked by preparing them for stigmatizing questions and providing counterarguments. Providers receive training and complete study assessments, while patients interact with trained or control group providers during their usual care.
Participants include lung cancer patients under care of participating OCPs, speaking English or Spanish, with prior or current smoking history. Assessments include standardized patient evaluations of communication and empathy skills at 3 months, along with patient-reported outcomes on lung cancer stigma, clinician empathy, communication satisfaction, psychological distress, and overall experience. The study monitors referrals to tobacco cessation and explores demographic and illness-related factors influencing outcomes. The trial is conducted nationally with randomized, double-masked design and runs until 2027.
CONDITIONS
Brief Title
Empathic Communication Skills (ECS) Training
Research Team
S
Smita Banerjee, PhD
J
Jamie Ostroff, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
ECS Training for Oncology Care Providers
Usual Provider Interaction (Standard Care)
What it is
A structured 2.25-hour empathic communication skills training program delivered to oncology care providers; focuses on identifying and addressing empathic opportunities, reducing lung cancer stigma, and preparing providers to help patients handle recurring smoking-related stigma.
Regular provider-patient interactions without additional ECS training; providers use their usual approach and skills for communicating and supporting lung cancer patients.
Role in trial
Intervention group: OCPs receive ECS training to enhance communication and empathy with lung cancer patients who are current or former smokers. Participating sites randomize providers and patients to this arm.
Comparator group: OCPs and their patients continue usual care without ECS-specific training. Providers and patients are assigned to this arm via randomization.
Primary use
Enhancing provider ability to recognize and respond to empathy opportunities, reduce patient distress and lung cancer stigma, and equip patients with strategies to handle recurring smoking questions.
Maintaining the existing provider-patient interaction and care for individuals with lung cancer, without structured ECS enhancement.
How it is given or performed
ECS training is delivered as a single 2.25-hour module to oncology care providers. Training includes roleplay, communication tools, and strategies for addressing lung cancer stigma and preparing patients for recurring smoking-related questions.
Providers continue regular patient interactions as per usual clinical practice. No additional ECS training is offered.
Evidence status
ECS training effectiveness is under investigation; prior studies demonstrate feasibility and preliminary positive effects on provider communication and reducing stigma in lung cancer patients, but definitive outcome evidence awaits completion of the current randomized trial.
Usual provider interaction and communication is established as current practice in oncology care; research identifies limitations in responding to empathic opportunities and mitigating lung cancer stigma, especially for patients who are current or former smokers.
Important limitations
ECS training is a behavioral educational intervention; its effectiveness, impact on patient outcomes, and scalability across diverse oncology populations are not yet fully established. The current trial aims to provide more definitive evidence. Feasibility and preliminary effects have been reported, but results may not generalize outside trial settings or to non-participating providers.
Usual provider interaction may lack structured tools or training for addressing lung cancer stigma and recurring smoking-related distress in patients. Research identifies gaps in responding to patient needs and empathic opportunities.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 100Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
The site employs at least 15 full-time oncology care providers including oncologists, nurse practitioners, and physician assistants
The site sees at least 20 new lung cancer patients per month
Oncology care providers are thoracic oncology physicians, nurse practitioners, or physician assistants currently treating lung cancer patients
Providers conduct consultations with lung cancer patients and see at least one lung cancer patient per week
Patients are under care of a participating provider
Patients speak English or Spanish
Patients are at least 18 years old
Patients have a history of suspicious lung mass or confirmed lung cancer diagnosis
Patients are former or current smokers
Patients have had no more than 10 visits with the participating provider
You will not qualify if you...
Patients with impaired decision-making capacity as judged by a clinician or documented in medical records
No exclusions for sites or oncology care providers
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit for eligibility assessment
Training and Patient Interaction
Duration - 3 months
Oncology care providers receive a 2.25-hour empathic communication skills training. Patients continue their usual care with providers who have completed the training or are part of the waitlist control group.
Regular clinical visits with providers
Assessment
Duration - Up to 1 month after training
Providers and patients complete evaluations including standardized patient assessments and surveys about stigma, empathy, and satisfaction.
1 to 2 evaluation visits
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
4
Similar Trials
Using 3-D Virtual Lung Resection to Predict Lung Function After VATS Surgery for Non-Small Cell Lung Cancer
Developing Advanced 4D-MRI Imaging to Improve Radiation Therapy for Lung and Liver Cancer
Including Healthy Adult Volunteers for Imaging Research
Exploratory Study of 68Ga-SorB PETCT Imaging to Diagnose Sortilin-Positive Solid Tumors
A Clinical and Biological Database Study of Lung Cancer Patients Receiving Standard Treatments
Study on Causes and Impact of Vulnerability in Adult Men With Serious Diseases Including Cancer and Fractures
Community Health Approaches to Increase Lung Cancer Screening and Tobacco Treatment in Community Health Centers
Feasibility Study of MRI-Guided Stereotactic Ablative Radiotherapy for Abdominal and Lung Tumors
Phase 12 Study of 3H-10000 Infusion for Adults with Unresectable or Metastatic Lung or Stomach Cancer
AI-Based PETCT Imaging for Detailed Lung Cancer Subtyping and Genetic Mutation Prediction
A Study Testing Mobile Health Technology to Improve Lung Cancer Screening Among Adults Aged 50 to 77
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Getting ready for prime time: Recommended adaptations of an Empathic Communication Skills training intervention to reduce lung cancer stigma for a national multi-center trial.
Smita C Banerjee, Charlotte D Malling, Megan J Shen...